Winning streak intact at D-Street; Sensex gains 3% for the week
The expectations of a good monsoon supported the rally in consumer and auto stocks
)
Explore Business Standard
The expectations of a good monsoon supported the rally in consumer and auto stocks
)
Gaurang Shah, vice-president, Geojit BNP Paribas said, "The market continues to traverse an uptrend with the Nifty touching 8350 spot levels. Some profit booking was seen at higher levels on last trading day of week and first trading day of July after the F&O contracts expiry."
Further he said, "From next week, the market is likely to witness some consolidation as it moves towards 8400-8450 levels and reaches 8500 levels."
Consolidating the macroeconomic story, the manufacturing activity for the month of June climbed up to a three month high led by a stronger demand. According to the Nikkei/Markit Manufacturing Purchasing Managers' Index (PMI), the manufacturing activity was clocked in at 51.7 for June against 50.7 in May.
The weather department on Thursday said that the southwest monsoon is expected to pick pace in July and August thus reinforcing investors' confidence.
Globally, Asian markets finished higher on Friday as hints of an accommodative monetary policy by central banks post Brexit shock have calmed investors' nerves around the world. Japan's Nikkei and Hong Kong's HangSeng finished higher between 0.7-1.7 per cent. The major European indices have also risen and are trading in the positive territory.
In the currency market, euro and pound came under fresh pressure as investors turned towards safer havens such as yen.
On Friday, crude oil, however, eased as concerns over supply glut resurfaced with OPEC reaching a record high production in June. Brent crude futures were down 30 cents at $49.41 a barrel at 5 pm IST.
Among the sectors, BSE Capital Goods index surged over 2% on upbeat manufacturing data. BHEL, L&T, Havells, Solar Industries India all gained between 2-3.5 per cent each.
Nifty Pharma index set to register its biggest weekly gain in past six months after US drug regulator successfully inspected manufacturing facilities of three pharma companies. Dr. Reddy's, Cipla, Lupin gained between 1-3 per cent each.
Meanwhile, the Foreign Institutional Investors (FIIs) were the net sellers to the tune of Rs 187.5 crore on Friday as per stock exchange data.
First Published: Jul 02 2016 | 12:13 AM IST